Which Insider bought 6000 Shares Of Bristol-Myers Squibb Company (BMY)?

More notable recent Bristol-Myers Squibb Co (NYSE:BMY) news were published by: Seekingalpha.com which released: “Bristol-Myers – Adding To The Pipeline With IFM” on August 07, 2017, also Nj.com with their article: “Bristol-Myers Squibb plans 58 layoffs as drug patents expire” published on August 08, 2017, Crainsdetroit.com published: “Bristol-Myers Squibb to acquire UM researcher-lead IFM Therapeutics in $2.32 …” on August 04, 2017. It increased, as 7 investors sold Loxo Oncology Inc shares while 15 reduced holdings. With 2.83 million avg volume, 0 days are for INTEGRAL TECHNLGS INCORPORATED (OTCMKTS:ITKG)’s short sellers to cover ITKG’s short positions. The SI to Epr Properties’s float is 3.37%. The stock increased 1.47% or $1 on August 25, reaching $69.15. About shares traded. NXP Semiconductors NV (NASDAQ:NXPI) has risen 24.67% since August 28, 2016 and is uptrending. It has underperformed by 16.70% the S&P500.The move comes after 9 months positive chart setup for the $6.89 billion company.

Oxbow Advisors Llc decreased Bristol Myers Squibb Co (BMY) stake by 67.12% reported in 2016Q4 SEC filing. $5.27 million worth of Bristol-Myers Squibb Co (NYSE:BMY) shares were sold by LEUNG SANDRA. The Patten & Patten Inc holds 129,711 shares with $7.58M value, up from 35,205 last quarter. The stock increased 0.27% or $0.16 on August 25, reaching $58.37. About shares traded. Bristol-Myers Squibb Co (NYSE:BMY) has declined 23.19% since August 28, 2016 and is downtrending. It has underperformed by 39.89% the S&P500. Stifel Nicolaus maintained the stock with “Buy” rating in Tuesday, August 8 report. The company has market cap of $6.89 billion. It has a 20.37 P/E ratio. The Company’s divisions include Entertainment, Education, Recreation and Other. Penobscot Investment Mngmt invested in 0.29% or 14,125 shares. Its down 0.16, from 1.13 in 2016Q3. Tarbox Group invested in 541 shares. It also reduced Gaming & Leisure Pptys Inc (Put) stake by 14,200 shares and now owns 185,800 shares. Metropolitan Life Insur Company Ny holds 10,559 shares. 198.07 million shares or 0.32% less from 198.70 million shares in 2016Q3 were reported. The biopharmaceutical company reported $0.74 EPS for the quarter, beating the Zacks’ consensus estimate of $0.73 by $0.01. Mcf Advisors Ltd Liability Company owns 7,765 shares. Wedge L L P Nc holds 1.42M shares. Baker Bros Advsr Limited Partnership has 137,735 shares. North Star Invest Mngmt has 50 shares. Schnieders Capital Mngmt Limited Liability invested in 11,931 shares or 0.36% of the stock.

Pentwater Capital Management Lp increased Nxp Semiconductors N V (NXPI) stake by 861.16% reported in 2016Q4 SEC filing. Following the completion of the purchase, the director now directly owns 18,000 shares in the company, valued at $1,006,920. Oppenheimer maintained Loxo Oncology Inc (NASDAQ:LOXO) on Tuesday, August 4 with “Buy” rating. Deutsche Bank has “Hold” rating and $52 target. On Friday, January 22 the stock rating was upgraded by Berenberg to “Buy”. The rating was maintained by Jefferies on Monday, July 17 with “Buy”. The firm has “Equal-Weight” rating by Morgan Stanley given on Friday, August 5. The firm has “Neutral” rating given on Thursday, June 22 by Susquehanna. The stock has “Mkt Perform” rating by FBR Capital on Thursday, February 25.

Since February 27, 2017, it had 0 buys, and 6 sales for $10.59 million activity. The portion of a company’s profit allocated to each outstanding share of common stock was $6.97 a share in the trailing twelve months. Rosenblum Silverman Sutton S F Inc sold 17,690 shares as the company’s stock declined 1.04% while stock markets rallied. 8,096 shares valued at $463,779 were sold by Caldarella Joseph C on Wednesday, March 15. Ghost Tree Capital Limited Liability Com has 1.41% invested in Bristol-Myers Squibb Co (NYSE:BMY).

It is down 0.00% since August 28, 2016 and is. It dived, as 86 investors sold BMY shares while 529 reduced holdings.

The most recent non open market insider trade was completed by GORDON MURDO on 08/01/2017, and was a disposition of 783 shares with a final price of $56.1. Bluecrest Cap Limited invested in 0.09% or 28,500 shares. Burke & Herbert Comml Bank accumulated 13,170 shares or 0.7% of the stock.

The top 5 institutional holders, in ascending order, are as follows: WELLINGTON MANAGEMENT GROUP LLP with 151 million shares, VANGUARD GROUP INC with 118.66 million shares, BLACKROCK INC. with 99.45 million shares, STATE STREET CORP with 67.72 million shares, and FMR LLC with 36.59 million shares. Sheets Smith Wealth accumulated 0.93% or 51,200 shares. The legal version of this story can be viewed at https://weekherald.com/2017/08/28/ci-investments-inc-has-102-65-million-stake-in-bristol-myers-squibb-company-bmy.html. Company insiders own 0.23% of the company’s stock. Geode Cap Mgmt Lc reported 92,083 shares. Godshalk Welsh Capital Management owns 4,250 shares. Mercer Advisers holds 0.19% or 3,990 shares in its portfolio. Calamos Advisors Ltd invested in 0.07% or 147,915 shares. 12,000 Bristol-Myers Squibb Co (NYSE:BMY) shares with value of $681,240 were bought by Samuels Theodore R. II. 1St Source Savings Bank has 66,154 shares for 0.37% of their portfolio. Apollo Invt Corp (NASDAQ:AINV) was raised too. Piper Jaffray Companies set a $60.00 target price on Bristol-Myers Squibb and gave the company a “hold” rating in a report on Thursday, July 27th.

Leave a Reply

Your email address will not be published. Required fields are marked *